The Centers for Medicare & Medicaid Services has issued final Medicare payment rates for clinical diagnostic laboratory tests and advanced diagnostic laboratory tests in calendar year 2018. The rates are based on the weighted median of private insurer payment rates, as required by a 2016 final rule implementing changes to the Medicare clinical laboratory fee schedule under the Protecting Access to Medicare Act. In response to public comments, CMS made a number of changes to the final rates. These include changes to the national limitation amount for certain laboratory test codes; a payment floor for certain diagnostic and screening pap smears; and changes to the payment rate for home use hemoglobin A1c kits. CMS also deleted a procedure code that is not used on Medicare claims and corrected errors in the procedure codes for CYs 2019 and 2020. Twenty-three organizations, including the AHA, had urged CMS to suspend implementation of new payment rates, citing significant concerns with the data collection process used to establish the rates.

Related News Articles

Perspective
As a politically practical matter, we need to focus on finding consensus to improve the system we have rather than subject the nation to yet another polarizing…
Headline
The AHA today urged the Centers for Medicare…
Headline
The AHA Friday shared recommendations for developing a unified post-acute care prospective payment system as required by the Improving Medicare Post-Acute Care…
Headline
The Centers for Medicare…
Headline
The Department of Health and Human Services’ Center for Medicare and Medicaid Innovation today announced a new payment model for emergency ambulance services…
Headline
The AHA today expressed support for the Resident Physician Shortage Reduction Act, legislation that would add 15,000 Medicare-funded residency positions over…